Professor Yuqin Wang has a BSc from Beijing Medical University and a PhD from Karolinska Institute in Stockholm. Dr. Wang’s research focuses on cholesterol metabolism in health and disease. She has extensive experience in applying mass spectrometry to study sterol-protein interactions. She is a co-inventor on the US patent, “Kit and method for quantitative detection of steroids” and has applied this technology to identify the endogenous cholesterol metabolites in embryonic brain which are important for neurogenesis. Along with Professor Griffiths, she has exploited this technology for the identification and quantification of sterols in biofluids, especially in the context of neurodegeneration. Dr. Wang’s group recently developed an advanced mass spectrometry imaging method targeting on low abundance biologically active sterols. This provides a powerful tool to investigate spatial cholesterol metabolism in healthy and diseased tissues. Dr. Wang brings her extensive experience in sterol analysis using liquid-chromatography-mass spectrometry to the current project